Background
==========

Common complex diseases such as cardiovascular disease, cancer, and autoimmune disorders; metabolic conditions such as diabetes and obesity, as well as neurological and psychiatric disorders make up a majority of health morbidity and mortality in developed countries. The specific genetic contributions to disease etiology and relationships to environmental factors in common disorders are unclear; complicated by many factors such as gene-gene interactions, the balance between susceptibility and protective alleles, copy number variation, low relative risk contributed by each gene, and a myriad of complex environmental inputs.

Genetic association studies using a candidate gene approach and more recently whole genome association studies (GWAS) have produced a large and rapidly increasing amount of information on the genetics of common disease. In parallel, mouse genetic models for human disease have provided a wealth of genetic and phenotypic information. While not always perfect models for human common complex disorders, the genetic purity and experimental flexibility of mouse disease models have produced valuable insights relevant to human disease.

Gene nomenclature standardization\[[@B1]\], database efforts \[[@B2]-[@B4]\], and phenotype ontology projects\[[@B5]\] in both human and mouse over the past decade have provided the foundation for integration of information on genetic contributions to disease and phenotypes. This allows the opportunity for systematic comparison and higher order systems analysis of disease and phenotypic information. In this report, we summarize and integrate large scale information on human genetic association information and mouse genetically determined phenotypic information with the goal of identifying fundamental relationships in human disease and mouse models of human disease.

Methods
=======

The Genetic Association Database
--------------------------------

The Genetic Association Database \[[@B2]\] (GAD) <http://geneticassociationdb.nih.gov> is an archive of summary data of published human genetic association studies of many common disease types. GAD is primarily focused on archiving information on common complex human disease rather than rare Mendelian disorders as found in the Online Mendelian Inheritance in Man (OMIM)\[[@B6]\]. GAD contains curated information on candidate gene studies and more recently on genome wide association studies. It builds on the curation of the CDC HuGENet info literature database \[[@B3]\] in part by adding molecular and ontological annotation creating a bridge between epidemiological and molecular information. This allows the large-scale integration of disease based genetic association information with genomic and molecular information as well as with the software tools and computational approaches and that use genomic information \[[@B7]-[@B12]\]. This report is a summary and analysis of the genes and diseases with positive associations in the Genetic Association Database with regard to replication, comparisons between diseases, and within broad phenotypic disease classes. Although GAD contains information on gene variation, this report is at the gene level only and does not consider specific gene variation or genetic polymorphism.

The Genetic Association Database (GAD) currently contains approximately 40,000 individual gene records of genetic association studies taken from over 23,000 independent publications. Importantly, a large number (11,568) of the records in GAD have a designation of whether the gene of record was reported to be associated (Y) or was not (N) associated with the disease phenotype for that specific record. Many records, for various reasons, do not have such a designation. In addition, a portion of the database records have been annotated with standardized disease phenotype keywords from the MeSH <http://www.nlm.nih.gov/mesh/> vocabulary. The GAD summations shown below are a subset of the records in GAD. They only include those records that are both; a) positively associated with a disease phenotype, and b) have a MeSH disease phenotype annotation. This represents a subset of 10,324 records having both positive associations to disease and records with MeSH annotations. Records designated as not associated (N) with a disease phenotype and those without MeSH disease annotation are not considered at this time in this report.

Mouse phenotypic database
-------------------------

The mouse phenotypic information described here was obtained from the Mouse Genome Informatics (MGI) database \[[@B4]\]<http://www.informatics.jax.org/> Phenotypes, Alleles and Disease Models section. The file used for mouse phenotypic information (see methods) is comprised of 5011 unique genes and 5142 unique phenotypic terms derived from information from specific gene mutations in multiple mouse strains. The mouse phenotypic information had been annotated to the mouse gene mutation records using Mammalian Phenotype terms and codes in the mouse phenotype database as a component of the Mouse Phenotyping Project \[[@B5],[@B13]\].

Quantitation of genes and disease phenotypes
--------------------------------------------

Quantitation of how often a disease phenotype was positively associated with a gene was performed as follows. GAD records having both recorded positive associations and annotated MeSH disease keywords were extracted and stored in a database according to their relationships. Using a perl script, the number of times of co-occurrence of a MeSH disease keyword was positively associated with a specific gene was recorded as found in the GAD database. These counts were sorted in declining order for each unique gene grouped by the disease MeSH term with which they are associated.

Mouse phenotypic information
----------------------------

The mouse phenotypic information described here was obtained from the Mouse Genome Informatics (MGI) <http://www.informatics.jax.org/>; Phenotypes, Alleles and Disease Models section; <ftp://ftp.informatics.jax.org/pub/reports/index.html#pheno>

Using these three files downloaded on 4-4-2008

<ftp://ftp.informatics.jax.org/pub/reports/MPheno_OBO.ontology>

<ftp://ftp.informatics.jax.org/pub/reports/MGI_PhenotypicAllele.rpt>

<ftp://ftp.informatics.jax.org/pub/reports/MGI_PhenoGenoMP.rpt>

The mouse phenotype files were extracted using a perl script annotating each gene with the phenotype term associated with each Mammalian Phenotype (MP) code.

Venn Diagram overlap of individual gene lists
---------------------------------------------

Individual GAD primary gene sets were analyzed using Venny\[[@B14]\]<http://bioinfogp.cnb.csic.es/tools/venny/index.html>. Pathway Venn Diagram comparisons were performed by placing individual GAD primary gene sets into WebGestalt \[[@B15]\]<http://bioinfo.vanderbilt.edu/webgestalt/> to identify KEGG pathways, then placing the resulting pathway names into Venny.

Dendrogram analysis of gene sets
--------------------------------

Relationships between diseases were identified by a unique method similar to phyologenetic classification. First the distance between the diseases were calculated by pairwise comparison of the diseases by finding the common genes between the pairs and dividing it by the smallest group of the pair. This number was then subtracted from 1. This step was done because if two lists are identical (100% match) then the resultant distance should be 0. This is represented in the formula:

Where: *C*~*k*~: Genes in each disease set (where *k*= *i*, *j*); N(*C*~*k*~): Number of genes in each disease set (where *k*= *i*, *j*); d~ij~is the pairwise distance; *i, j*: index of genes in each disease set where; *i*= 1, 2, 3, \...\...\..., *n*; *j*= 1, 2, 3, \...\...\..., *m*

The disease relationships were calculated from the distance matrix using the Fitch program from the Phylip package\[[@B16]\]. It calculates the relationships based on the Fitch and Margoliash method of constructing the phylogenetic trees\[[@B17]\] using the following formula (from the Phylip manual):

where *D*is the observed distance between gene sets *i*and *j*and *d*is the expected distance, computed as the sum of the lengths of the segments of the tree from gene set *i*to gene set *j*. The quantity *n*is the number of times each distance has been replicated. In simple cases *n*is taken to be one. If *n*is chosen more than 1, the distance is then assumed to be a mean of those replicates. The power *P*is what distinguished between the Fitch and Neighbor-Joining methods. For the Fitch-Margoliash method P is 2.0 and for Neighbor-Joining method it is 0.0. As running Fitch took a long time when the gene-set size was huge (weeks for the human gene-sets and months for the mouse gene-sets), Neighbor-Joining method was used to create the replicate dendrograms (not shown) after randomizing the input order for greater confidence. The resulting coefficient matrix files were displayed using the Phylodraw graphics program\[[@B18]\].

Hierarchical clustering of gene sets
------------------------------------

Ward\'s minimum variance method\[[@B19]\] was used to find the distance between two diseases. The distance between the clusters is the ANOVA sum of squares between the two clusters added up over all the variables. At each generation, the within-cluster sum of squares is minimized over all partitions obtainable by merging two clusters from the previous generation. Ward\'s method joins clusters to maximize the likelihood at each level of the hierarchy under the assumptions of multivariate normal mixtures, spherical covariance matrices, and equal sampling probabilities. Distance for Ward\'s method is: (taken from JMP Manual) where N~K~is the number of observations in C~K~(which is the Kth cluster, subset of {1, 2, \..., n) where n is the number of observations). is the mean vector for cluster C~K~.

Results
=======

Each record in GAD represents a specific gene from a unique publication of a human population based genetic association study and is categorized into one of 24 general disease classes corresponding to broad MeSH disease or disease phenotypic groupings. Table [1](#T1){ref-type="table"} is a summary of the number of positively associated human genes in each MeSH human disease class. As represented by these disease classes the GAD database covers a broad selection of diseases falling into major disease classes including; aging studies, cancer, immune disorders, psychiatric diseases, metabolic conditions, pharmacogenomic studies, and studies of chemical dependency, among others. Similarly, each record in the phenotype files from the MGI phenotype database represents a unique mouse gene specific genetic model. Table [2](#T2){ref-type="table"} shows the general categories represented by the mouse phenotype summary files and the number of mouse genes found in each top level phenotype class. The mouse files contain a greater number of intermediate developmental and morphological phenotypes (e.g. insulin resistance, absent CD4+ T cells, abnormal spatial learning) while the human files tend to comprise a greater number of end stage clinical disease phenotypes (e.g. Type 2 Diabetes, multiple sclerosis, autism).

###### 

Number of human genes associated in each Disease Class

  DISEASE CLASS                                                     \# of human genes in each disease class
  ----------------------------------------------------------------- -----------------------------------------
  Neoplasms                                                         1835
  Cardiovascular Diseases                                           1112
  Pathological Conditions, Signs and Symptoms                       938
  Nervous System Diseases                                           902
  Nutritional and Metabolic Diseases                                838
  Mental Disorders                                                  554
  Digestive System Diseases                                         407
  Male Urogenital Diseases                                          396
  Musculoskeletal Diseases                                          366
  Respiratory Tract Diseases                                        362
  Bacterial Infections and Mycoses                                  256
  Disorders of Environmental Origin                                 243
  Female Urogenital Diseases and Pregnancy Complications            226
  Virus Diseases                                                    224
  Skin and Connective Tissue Diseases                               212
  Hemic and Lymphatic Diseases                                      183
  Eye Diseases                                                      176
  Congenital, Hereditary, and Neonatal Diseases and Abnormalities   142
  Stomatognathic Diseases                                           130
  Immune System Diseases                                            116
  Endocrine System Diseases                                         98
  Parasitic Diseases                                                57
  Otorhinolaryngologic Diseases                                     35
  Animal Diseases                                                   4

###### 

Number of Mouse genes in each General Phenotypic Class

  PHENOTYPIC CLASS                     \# of Mouse genes in each class
  ------------------------------------ ---------------------------------
  unassigned top level                 19186
  nervous system phenotype             8149
  immune system phenotype              6414
  homeostasis/metabolism phenotype     5976
  skeleton phenotype                   5559
  growth/size phenotype                5556
  behavior/neurological phenotype      5417
  cardiovascular system phenotype      5221
  hematopoietic system phenotype       5163
  reproductive system phenotype        4762
  lethality-prenatal/perinatal         4409
  embryogenesis phenotype              3416
  skin/coat/nails phenotype            3048
  vision/eye phenotype                 2710
  hearing/vestibular/ear phenotype     2447
  muscle phenotype                     2370
  cellular phenotype                   2335
  normal phenotype                     2120
  renal/urinary system phenotype       2104
  endocrine/exocrine gland phenotype   1871
  life span-post-weaning/aging         1857
  respiratory system phenotype         1832
  digestive/alimentary phenotype       1780
  lethality-postnatal                  1777
  liver/biliary system phenotype       1498
  limbs/digits/tail phenotype          1282
  tumorigenesis                        1268
  adipose tissue phenotype             1067
  craniofacial phenotype               1016
  pigmentation phenotype               634
  touch/vibrissae phenotype            625
  no phenotypic analysis               403
  other phenotype                      343
  taste/olfaction phenotype            156

Table [3](#T3){ref-type="table"} introduces examples of human genes from fundamental biological pathways that have been consistently associated with major disease phenotypes highlighting the sometimes-broad pleiotropic effects that major regulatory molecules have on multiple disease phenotypes. Genes such as *NOS3*, nitric oxide synthase 3, regulating nitrous oxide production; *HLA-DQB1*, the MHC class II molecule DQ beta 1, involved in antigen presentation; *ACE*, angiotensin I converting enzyme, central to the renin-angiotensin system and *PPARG*, peroxisome proliferator-activated receptor gamma, regulating transcription in pathways important in lipid metabolism are examples of genes that affect multiple tissues and different organ systems through the complex course of disease progression. Importantly, all the mouse orthologs of the human genes in Table [3](#T3){ref-type="table"} have experimentally determined phenotypes that are similar or broadly overlapping with human clinical disease phenotypes (see below).

###### 

Selected Major Genes and Disease Phenotypes

  Gene                                            Gene          
  -------------- -------------------------------- ------------- ----------------------------------
  **APOE**       ALZHEIMER DISEASE (70)           **VDR**       PROSTATIC NEOPLASMS (10)
                 CORONARY DISEASE (8)                           OSTEOPOROSIS, POSTMENOPAUSAL (8)
                 CARDIOVASCULAR DISEASES (7)                    BREAST NEOPLASMS (7)
                 MYOCARDIAL INFARCTION (6)                      DIABETES MELLITUS, TYPE 1 (6)
                 DIABETES MELLITUS, TYPE 2 (6)                  OSTEOPOROSIS (6)
                                                                
  **ACE**        HYPERTENSION (47)                **MTHFR**     NEURAL TUBE DEFECTS (6)
                 DIABETES MELLITUS, TYPE 2 (25)                 COLORECTAL NEOPLASMS (5)
                 MYOCARDIAL INFARCTION (17)                     DIABETES MELLITUS, TYPE 2 (5)
                 CORONARY DISEASE (16)                          ESOPHAGEAL NEOPLASMS (5)
                 DIABETIC NEPHROPATHIES (15)                    ADENOCARCINOMA (4)
                                                                
  **HLA-DQB1**   DIABETES MELLITUS, TYPE 1 (30)   **CYP17A1**   BREAST NEOPLASMS (10)
                 PAPILLOMAVIRUS INFECTIONS (7)                  PROSTATIC NEOPLASMS (9)
                 CELIAC DISEASE (6)                             PROSTATIC HYPERPLASIA (4)
                 AUTOIMMUNE DISEASES (5)                        OSTEOPOROSIS, POSTMENOPAUSAL (3)
                 TUBERCULOSIS, PULMONARY (5)                    ENDOMETRIAL NEOPLASMS (2)
                                                                
  **DRD2**       ALCOHOLISM (17)                  **ADRB2**     ASTHMA (12)
                 SCHIZOPHRENIA (14)                             OBESITY (10)
                 PERSONALITY DISORDER (2)                       HYPERTENSION (8)
                 DEPRESSIVE DISORDER (2)                        DIABETES MELLITUS, TYPE 2 (4)
                 DYSKINESIA, DRUG INDUCED (2)                   BRONCHIAL HYPERREACTIVITY (4)
                                                                
  **PPARG**      DIABETES MELLITUS, TYPE 2 (18)   **NOS3**      HYPERTENSION (20)
                 OBESITY (11)                                   MYOCARDIAL INFARCTION (18)
                 DIABETES MELLITUS (6)                          CORONARY ARTERY DISEASE (15)
                 INSULIN RESISTANCE (4)                         CORONARY DISEASE (12)
                 GLUCOSE INTOLERANCE (2)                        DIABETES MELLITUS, TYPE 2 (10)

Summaries of genes and phenotypes in human and mouse
----------------------------------------------------

The majority of this report is built upon large non-redundant general summary lists for both human and mouse, shown below. These lists take two complimentary forms in both human and mouse. The first sets are GENE-to-Disease/Phenotype lists. These are non-redundant lists of genes showing the diseases or phenotypes that have been associated with each gene (Table [4](#T4){ref-type="table"} human, table [5](#T5){ref-type="table"} mouse, and table [6](#T6){ref-type="table"} human-mouse). The second sets of basic lists are DISEASE/PHENOTYPE-to-Gene lists. These are non redundant lists of diseases or phenotypes with the genes that have been associated with that disease or phenotype (Table [7](#T7){ref-type="table"} human and table [8](#T8){ref-type="table"} mouse).

###### 

Selected Human Genes and Disease Phenotype (MeSH counts), positive associations

  Gene ID   HUGO Gene Sym.   MESH TERM 1                               MESH TERM 2                       MESH TERM 3                          MESH TERM 4
  --------- ---------------- ----------------------------------------- --------------------------------- ------------------------------------ ------------------------------------
  348       **APOE**         Alzheimer Disease(70)                     Coronary Disease(8)               Cardiovascular Diseases(7)           Diabetes Mellitus, Type 2(6)
  1636      **ACE**          Hypertension(47)                          Diabetes Mellitus, Type 2(25)     Myocardial Infarction(17)            Coronary Disease(16)
  3119      **HLA-DQB1**     Diabetes Mellitus, Type 1(30)             Papillomavirus Infections(7)      Celiac Disease(6)                    Tuberculosis, Pulmonary(5)
  1493      **CTLA4**        Diabetes Mellitus, Type 1(28)             Graves Disease(21)                Thyroiditis, Autoimmune(10)          Autoimmune Diseases(8)
  183       **AGT**          Hypertension(24)                          Coronary Disease(6)               Diabetic Nephropathies(5)            Myocardial Infarction(5)
  1814      **DRD3**         Schizophrenia(24)                         Dyskinesia, Drug-Induced(6)       Psychotic Disorders(5)               Alcoholism(2)
  4846      **NOS3**         Hypertension(20)                          Myocardial Infarction(18)         Coronary Artery Disease(15)          Coronary Disease(12)
  3075      **CFH**          Macular Degeneration(19)                  Choroidal Neovascularization(3)   Hemolytic-Uremic Syndrome(2)         Atrophy(2)
  3077      **HFE**          Hemochromatosis(18)                       Cardiovascular Diseases(1)        Colorectal Neoplasms(1)              Liver Cirrhosis(1)
  3356      **HTR2A**        Schizophrenia(18)                         Alzheimer Disease(4)              Depressive Disorder(4)               Depressive Disorder, Major(4)
  1585      **CYP11B2**      Hypertension(18)                          Cardiovascular Diseases(2)        Ventricular Dysfunction, Left(2)     Cardiomyopathy, Dilated(2)
  5468      **PPARG**        Diabetes Mellitus, Type 2(18)             Obesity(11)                       Diabetes Mellitus(6)                 Insulin Resistance(4)
  2784      **GNB3**         Hypertension(18)                          Insulin Resistance(4)             Diabetes Mellitus, Type 2(3)         Obesity(3)
  1815      **DRD4**         Attention Def. Dis. with Hyperact. (17)   Schizophrenia(8)                  Substance-Related Disorders(4)       Mood Disorders(4)
  1813      **DRD2**         Alcoholism(17)                            Schizophrenia(14)                 Personality Disorders(2)             Depressive Disorder(2)
  155       **ADRB3**        Obesity(17)                               Diabetes Mellitus, Type 2(9)      Insulin Resistance(6)                Endometrial Neoplasms(2)
  9370      **ADIPOQ**       Diabetes Mellitus, Type 2(17)             Insulin Resistance(11)            Obesity(8)                           Hypertension(4)
  3123      **HLA-DRB1**     Arthritis, Rheumatoid(16)                 Diabetes Mellitus, Type 1(16)     Multiple Sclerosis(8)                Lupus Erythematosus, Systemic(7)
  118       **ADD1**         Hypertension(16)                          Cardiovascular Diseases(3)        Cerebral Hemorrhage(1)               Diabetic Angiopathies(1)
  3117      **HLA-DQA1**     Diabetes Mellitus, Type 1(15)             Graves Disease(4)                 Autoimmune Diseases(4)               Celiac Disease(4)
  1956      **EGFR**         Lung Neoplasms(15)                        Carcinoma, Non-SC Lung(10)        Adenocarcinoma(6)                    Neoplasm Recurrence, Local(3)
  6690      **SPINK1**       Pancreatitis(15)                          Chronic Disease(11)               Acute Disease(3)                     Pancreatitis, Alcoholic(3)
  6934      **TCF7L2**       Diabetes Mellitus, Type 2(15)             Insulin Resistance(4)             Diabetes Mellitus(2)                 Liver Neoplasms(1)
  1234      **CCR5**         HIV Infections(14)                        Diabetes Mellitus, Type 2(4)      Diabetic Nephropathies(4)            Asthma(3)
  5663      **PSEN1**        Alzheimer Disease(14)                     Down Syndrome(2)                  Dementia(1)                          Cerebral Amyloid Angiopathy(1)
  11132     **CAPN10**       Diabetes Mellitus, Type 2(14)             Insulin Resistance(3)             Polycystic Ovary Syndrome(2)         Obesity(2)
  3553      **IL1B**         Stomach Neoplasms(14)                     Helicobacter Infections(6)        Alzheimer Disease(5)                 Periodontitis(3)
  6532      **SLC6A4**       Depressive Disorder, Major(13)            Depressive Disorder(13)           Bipolar Disorder(10)                 Alcoholism(8)
  4210      **MEFV**         Familial Mediterranean Fever(13)          Amyloidosis(4)                    Behcet Syndrome(3)                   Colitis, Ulcerative(2)
  3172      **HNF4A**        Diabetes Mellitus, Type 2(13)             Glucose Intolerance(2)            Birth Weight(1)                      Fetal Macrosomia(1)
  7157      **TP53**         Carcinoma, Squamous Cell(13)              Lung Neoplasms(12)                Breast Neoplasms(10)                 Carcinoma, Non-SC Lung(9)
  672       **BRCA1**        Breast Neoplasms(12)                      Ovarian Neoplasms(5)              Carcinoma, Endometrioid(1)           DNA Damage(1)
  185       **AGTR1**        Hypertension(12)                          Myocardial Infarction(3)          Coronary Disease(3)                  Pregnancy Comp., Cardiovascular(2)
  154       **ADRB2**        Asthma(12)                                Obesity(10)                       Hypertension(8)                      Diabetes Mellitus, Type 2(4)
  3953      **LEPR**         Obesity(12)                               Body Weight(4)                    Insulin Resistance(4)                Glucose Intolerance(3)
  2169      **FABP2**        Diabetes Mellitus, Type 2(12)             Insulin Resistance(10)            Obesity(7)                           Hyperlipidemias(4)
  929       **CD14**         Asthma(12)                                Myocardial Infarction(5)          Arteriosclerosis(4)                  Colitis, Ulcerative(4)
  26191     **PTPN22**       Arthritis, Rheumatoid(11)                 Diabetes Mellitus, Type 1(9)      Lupus Erythematosus, Systemic(5)     Arthritis, Psoriatic(2)
  3596      **IL13**         Asthma(11)                                Hypersensitivity, Immediate(4)    Pulmonary Dis., Chronic Obstr. (4)   Respiratory Hypersensitivity(2)
  1080      **CFTR**         Cystic Fibrosis(10)                       Pancreatitis(5)                   Chronic Disease(3)                   Acute Disease(2)

###### 

Selected Mouse Genes-Disease Phenotypes

  Mouse Gene Sym.   Human Ortholog Gene Sym.   Mouse Phenotype 1                  Mouse Phenotype 2                          Mouse Phenotype 3                          Mouse Phenotype 4                    Mouse Phenotype 5
  ----------------- -------------------------- ---------------------------------- ------------------------------------------ ------------------------------------------ ------------------------------------ --------------------------------------
  A4galt            A4GALT                     abnormal induced morb./mort.       abnormal resp./metab. to xenobiotics       life span-post-weaning/aging               homeostasis/metab. phenotype         
  Abca2             ABCA2                      tremors                            decreased body weight                      behavior/neurological phenotype            hyperactivity                        increased startle reflex
  Abcc2             ABCC2                      abnormal blood chemistry           abnormal liver physiology                  abnormal urine chemistry                   abnormal kidney physiology           Abn. resp./metabolism to xenobiotics
  Abi2              ABI2                       abn. corpus callosum morph.        abnormal cerebral cortex morph.            abnormal hippocampus morph.                abnormal dentate gyrus morph.        microphthalmia
  Acaca             ACACA                      abnormal liver physiology          abnormal lipid level                       incr. circulating free fatty acid level    hyperglycemia                        embryonic growth arrest
  Acads             ACADS                      hypoglycemia                       behavior/neurological phenotype            abnormal drinking behavior                 abnormal food preference             abnormal urine chemistry
  Accn1             ACCN1                      retinal degeneration               vision/eye phenotype                       abnormal eye electrophysiology                                                  
  Adad1             ADAD1                      impaired fertilization             male infertility                           asthenozoospermia                          oligozoospermia                      reproductive system phenotype
  Adam23            ADAM23                     tremors                            behavior/neurological phenotype            ataxia                                     postnatal lethality                  lethality-postnatal
  Adarb1            ADARB1                     behavior/neurological phenot.      seizures                                   postnatal lethality                        behavior/neurological phenotype      normal phenotype
  Adipoq            ADIPOQ                     vasculature congestion             increased body weight                      decreased body weight                      abnormal CNS syn. transmission       abnormal coat appearance
  Adora1            ADORA1                     behavior/neurological phenot.      increased anxiety-related response         abnormal body temperature regulation       abnormal angiogenesis                abnormal nervous system electrophys.
  Ager              AGER                       increased bone density             abnormal cancellous bone morph.            abnormal blood chemistry                   reproductive system phenotype        abnormal cell proliferation
  Akap1             AKAP1                      reduced female fertility           decreased litter size                      abnormal female meiosis                    increased cholesterol level          
  Apoc1             APOC1                      abnormal circ. cholesterol level   abnormal lipid level                       increased circulating triglyceride level   abnormal immune sys. Morph.          abnormal bile composition
  B2m               B2M                        decreased hematocrit               abnormal interleukin-10 physiology         rectal prolapse                            abnormal dorsal root gang. morph.    enlarged spleen
  Bax               BAX                        enlarged spleen                    increased thymocyte number                 abnormal motor neuron morph.               short snout                          abnormal sympathetic neuron morph.
  Bcl2              BCL2                       small ears                         absent melanin granules in hair follicle   abnormal snout morph.                      herniated abdominal wall             abnormal small intestine morph.
  Bmp1              BMP1                       abnormal heart morph.              abnormal aorta morph.                      abnormal ventricular septum morph.         abnormal awl hair                    prenatal lethality
  Brca1             BRCA1                      abnormal cell death                increased cell proliferation               decreased cell proliferation               decreased anxiety-related resp.      kinked tail
  Capn10            CAPN10                     abnormal pancreas physiology       endocrine/exocrine gland phenotype         digestive/alimentary phenotype             decreased inflammatory response      
  Casp1             CASP1                      abnormal apoptosis                 abnormal induced morbidity/mortality       abnormal inflammatory response             decr. suscep. to endotoxin shock     tumorigenesis
  Ccr4              CCR4                       immune system phenotype            decreased tumor necrosis factor secr.      decreased interleukin-1 beta secretion     abnormal induced morbid./mort.       
  Dusp1             DUSP1                      thick alveolar septum              abnormal circ. alanine transaminase        hypotension                                increased thymocyte number           lung inflammation
  E2f1              E2F1                       abnormal cell death                decreased salivation                       enlarged thymus                            pale liver                           exencephaly
  Epo               EPO                        abnormal erythropoiesis            abnormal pericardium morph.                small liver                                postnatal growth retardation         abnormal hepatocyte morph.
  Ercc4             ERCC4                      abnormal cell content/morph.       abnormal liver morph.                      decreased body weight                      absent blood islands                 liver/biliary system phenotype
  F5                F5                         behavior/neurological phenot.      abnormal somite development                abnormal yolk sac morph.                   increased suscep. to bact. Infect.   hemorrhage
  Fcgr1             FCGR1A                     impaired macrophage phagocyt.      abnormal inflammatory response             decreased inflammatory response            abnormal yolk sac morph.             abnormal cell-mediated immunity
  Foxo1             FOXO1                      absent organized vascular net.     abnormal looping morphogenesis             abnormal vasculature                       exencephaly                          absent vitelline blood vessels
  Gadd45a           GADD45A                    decreased leukocyte cell num.      increased cell proliferation               increased thymocyte number                 postnatal lethality                  skin irradiation sensitivity
  Gap43             GAP43                      decreased body weight              abnormal optic nerve innervation           absent optic tract                         abnormal erythropoiesis              nervous system phenotype
  Gata1             GATA1                      decreased hematocrit               abnormal thrombopoiesis                    extramedullary hematopoiesis               overexpanded resp. alveoli           liver hypoplasia
  Grin1             GRIN1                      abn. trigeminal nerve morph.       atelectasis                                lung hemorrhage                            abnormal tympanic ring morph.        decreased body weight
  Hoxa1             HOXA1                      small ears                         abnormal inner ear morph.                  abnormal malleus morph.                    increased susceptibility to injury   abnormal cochlea morph.
  Hspa1a            HSPA1A                     decreased body weight              increased cell. Sens. to gamma-irrad.      chromosome breakage                        increased body weight                homeostasis/metabolism phenotype
  Icam1             ICAM1                      increased leukocyte cell number    increased neutrophil cell number           increased monocyte cell number             abnormal spatial learning            abnormal retina morph.
  Igbp1             IGBP1                      decreased thymocyte number         behavior/neurological phenotype            abnormal cued conditioning behavior        intestinal ulcer                     abnormal thymus lobule morph.

###### 

Selected Human-Mouse Phenotype Overlap

  ----------------------------------------------------------------------------------------------------------------------------------------------------
  Mouse Gene Sym   Human Gene Sym   Human Gene ID \#   Human Disease MeshTerm                   Mouse Phenotype Term
  ---------------- ---------------- ------------------ ---------------------------------------- ------------------------------------------------------
  **Npc1l1**       **NPC1L1**       29881              Hypercholesterolemia(1)                  abnormal circulating LDL cholesterol level;\
                                                                                                decreased circulating HDL cholesterol level;\
                                                                                                abnormal triglyceride level;\
                                                                                                abnormal lipid homeostasis; \...

                                                                                                

  **Nkx2-5**       **NKX2-5**       1482               Heart Defects, Congenital(1),\           abnormal heart development;\
                                                       Heart Block(1)                           abnormal looping morphogenesis;\
                                                                                                abnormal heart tube morphology;\
                                                                                                abnormal heart shape;\
                                                                                                thin ventricular wall; \...

                                                                                                

  **Oprm1**        **OPRM1**        4988               Alcoholism(9),\                          abnormal response to addictive substance;\
                                                       Substance-Related Disorders(5),\         preference for addictive substance;\
                                                       Heroin Dependence(2), Pain,\             abnormal touch/nociception;\
                                                       Postoperative(2),\                       abnormal pain threshold;\
                                                       Epilepsy, Generalized(1),\               decreased chemically-elicited antinociception;\
                                                       Substance Withdrawal Syndrome(1),\       sensitivity to addictive substance;\
                                                       Cocaine-Related Disorders(1),\           excitatory postsyn. potential;\
                                                       Diabetes Mellitus, Type 2(1),\           resistance to addictive substance;\
                                                       Kidney Failure, Chronic(1),\             altered response to anesthetics; \...
                                                       Pain(1), Ischemia(1),\                   
                                                       Opioid-Related Disorders(1),\            
                                                       Postoperative Nausea and Vomiting(1)     

                                                                                                

  **Homer1**       **HOMER1**       9456               Cocaine-Related Disorders(1)             cocaine preference;\
                                                                                                abnormal conditioning behavior;\
                                                                                                abnormal response to addictive substance;\
                                                                                                nervous system phenotype;\
                                                                                                abnormal nervous system physiology;\
                                                                                                behavior/neurological phenotype, \...

                                                                                                

  **Insl3**        **INSL3**        3640               Cryptorchidism(3),\                      abnormal male reproductive anatomy;\
                                                       Abnormalities, Multiple(1),\             small testis;\
                                                       Hypospadias(1),\                         abnormal spermatogenesis;\
                                                       Gonadal Dysgenesis(1),\                  behavior/neurological phenotype;\
                                                       Infertility, Male(1),\                   male infertility;\
                                                       Testicular Diseases(1)                   female infertility;\
                                                                                                abnormal estrous cycle;\
                                                                                                abnormal gametogenesis;\
                                                                                                decreased germ cell number;\
                                                                                                cryptorchism; \...

                                                                                                

  **Stat6**        **STAT6**        6778               Asthma(3),\                              abnormal humoral immune response;\
                                                       Hypersensitivity(3),\                    decreased IgM level;\
                                                       Dermatitis, Atopic(2),\                  decreased IgA level;\
                                                       Anaphylaxis(2),\                         decreased susceptibility to viral infection;\
                                                       Nut Hypersensitivity(1),\                decreased IgE level;\
                                                       Nephrotic Syndrome(1),\                  increased IgG level;\
                                                       Infertility(1),\                         increased IgA level;\
                                                       Hypersensitivity, Immediate(1),\         abnormal interleukin physiology;\
                                                       Graves Disease(1),\                      abnormal interferon physiology;\
                                                       Endometriosis(1), \...                   abnormal CD8-positive T cell morphology; \...

                                                                                                

  **En2**          **EN2**          2020               Autistic Disorder(1),\                   [abnormal social investigation;]{.ul}\
                                                       Asperger Syndrome(1)                     [abnormal spatial learning;]{.ul}\
                                                                                                [abnormal social/conspecific interaction]{.ul};\
                                                                                                abnormal cerebellum morphology;\
                                                                                                abnormal cerebellar foliation;\
                                                                                                abnormal vermis morphology;\
                                                                                                abnormal cerebellar granule layer;\
                                                                                                abnormal colliculi morphology;\
                                                                                                hyperactivity;\
                                                                                                impaired coordination;\
                                                                                                abnormal grooming behavior; \...

                                                                                                

  **Hsd11b1**      **HSD11B1**      3290               Diabetes Mellitus, Type 2(2),\           abnormal abdominal fat pads;\
                                                       Obesity(2),\                             abnormal circulating cholesterol level;\
                                                       Hypertension(2),\                        decreased circulating LDL cholesterol level;\
                                                       Insulin Resistance(2),\                  enlarged adrenal glands;\
                                                       Polycystic Ovary Syndrome(1),\           increased circulating HDL cholesterol level;\
                                                       Hyperandrogenism(1)                      abnormal glucose homeostasis;\
                                                                                                decreased circulating triglyceride level;\
                                                                                                abnormal corticosterone level;\
                                                                                                improved glucose tolerance; \...

                                                                                                

  **Msh3**         **MSH3**         4437               Lung Neoplasms(1),\                      tumorigenesis;\
                                                       Head and Neck Neoplasms(1),\             increased tumor incidence;\
                                                       Colonic Neoplasms(1),\                   premature death;\
                                                       Carcinoma, Squamous Cell(1),\            life span-post-weaning/aging
                                                       Carcinoma, Small Cell(1)                 

                                                                                                

  **Crb1**         **CRB1**         23418              Optic Atrophies, Hereditary(1),\         abnormal retinal photoreceptor morphology;\
                                                       Blindness(1)                             abnormal retina morphology;\
                                                                                                retinal degeneration;\
                                                                                                decreased retinal photoreceptor cell number;\
                                                                                                photosensitivity;\
                                                                                                abnormal ocular fundus morphology;\
                                                                                                nervous system phenotype;\
                                                                                                abnormal retinal photoreceptor layer;\
                                                                                                abnormal photoreceptor inner segment morph; \...

                                                                                                

  **Chrna7**       **CHRNA7**       1139               Schizophrenia(3),\                       pharmacologically induced seizures;\
                                                       Auditory Perceptual Disorders(1),\       decreased anxiety-related response;\
                                                       Memory Disorders(1)                      abnormal spatial learning;\
                                                                                                abnormal hippocampus function;\
                                                                                                abnormal tumor necrosis factor physiology;\
                                                                                                homeostasis/metabolism phenotype

                                                                                                

  **Inha**         **INHA**         3623               [Ovarian Failure, Premature]{.ul}(2),\   kyphoscoliosis;\
                                                       Amenorrhea(1)                            abnormal liver morphology;\
                                                                                                [abnormal ovarian follicle morphology]{.ul};\
                                                                                                enlarged testes;\
                                                                                                abnormal spermatogenesis;\
                                                                                                increased circulating follicle stimulating hormone;\
                                                                                                male infertility;\
                                                                                                [female infertility]{.ul};\
                                                                                                tumorigenesis;\
                                                                                                [ovary hemorrhage]{.ul};\
                                                                                                cachexia;\
                                                                                                diffuse hepatic necrosis;\
                                                                                                pancytopenia;\
                                                                                                liver/biliary system phenotype; \...

                                                                                                

  **Slc6a3**       **SLC6A3**       6531               Attention Deficit Disorder w/Hyp.(7),\   abnormal maternal nurturing;\
                                                       Tobacco Use Disorder(3),\                hyperactivity; hypoactivity;\
                                                       Schizophrenia(2),\                       impaired coordination;\
                                                       Alcohol Withdrawal Delirium(2),\         increased exploration in new environment;\
                                                       Eating Disorders(1),\                    decreased exploration in new environment;\
                                                       Substance Withdrawal Syndrome(1),\       abnormal spatial learning;\
                                                       Stress Disorders, Post-Traumatic(1),\    abnormal pituitary secretion;\
                                                       Child Behavior Disorders(1),\            abnormal lactation;\
                                                       Bulimia(1),\                             increased dopamine level;\
                                                       Alcoholism(1),                           cocaine preference; \...

                                                                                                

  **Cyp11b2**      **CYP11B2**      1585               Hypertension(18),\                       decreased body size;\
                                                       Cardiovascular Diseases(2),\             hypotension;\
                                                       Ventricular Dysfunction, Left(2),\       increased circulating corticosterone level;\
                                                       Cardiomyopathy, Dilated(2),\             decreased circulating aldosterone level;\
                                                       Arteriosclerosis(1),\                    decreased circulating chloride level;\
                                                       Acromegaly(1),\                          increased circulating renin level;\
                                                       Fibrosis(1),\                            abnormal enzyme/coenzyme level;\
                                                       Arthritis, Rheumatoid(1),\               lethality-postnatal;\
                                                       Polycystic Ovary Syndrome(1),\           homeostasis/metabolism phenotype;\
                                                       Metabolic Syndrome X(1),                 growth/size phenotype; \...

                                                                                                

  **Ptpn22**       **PTPN22**       26191              Arthritis, Rheumatoid(11),\              enlarged spleen;\
                                                       Diabetes Mellitus, Type 1(9),\           enlarged lymph nodes;\
                                                       Lupus Erythematosus, Systemic(5),\       abnormal Peyer\'s patch germinal center morph;\
                                                       Arthritis, Psoriatic(2),\                abnormal T cell physiology;\
                                                       Autoimmune Diseases(2),\                 increased IgE level;\
                                                       Arthritis, Juvenile Rheumatoid(2),\      increased B cell number;\
                                                       Nephritis(1),\                           immune system phenotype;\
                                                       Multiple Sclerosis(1),\                  hematopoietic system phenotype;\
                                                       Asthma(1),\                              increased follicular B cell number;\
                                                       Cholangitis, Sclerosing(1),              increased spleen germinal center number;\
                                                                                                increased IgG1 level;\
                                                                                                increased IgG2a level; \...
  ----------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Selected Human Disease Phenotypes (MeSH) and Gene counts, positive associations

  Disease Mesh Term                                  Gene Rank 1   Gene Rank 2   Gene Rank 3    Gene Rank 4   Gene Rank 5   Gene Rank 6    Gene Rank 7   Gene Rank 8
  -------------------------------------------------- ------------- ------------- -------------- ------------- ------------- -------------- ------------- -------------
  **DISEASE CLASS - CARDIOVASCULAR**                                                                                                                     
  Hypertension                                       ACE(47)       AGT(24)       NOS3(20)       CYP11B2(18)   GNB3(18)      ADD1(16)       AGTR1(12)     ADRB2(8)
  Myocardial Infarction                              NOS3(18)      ACE(17)       SERPINE1(11)   ITGA2(7)      LPL(6)        APOE(6)        GP1BA(5)      F7(5)
  Coronary Disease                                   ACE(16)       NOS3(12)      PON1(11)       APOB(11)      APOE(8)       LPL(7)         AGT(6)        SERPINE1(6)
  Coronary Artery Disease                            NOS3(15)      PON1(9)       ACE(7)         APOA5(6)      APOE(5)       AGT(4)         ABCA1(4)      APOA1(4)
  Hypertrophy, Left Ventricular                      ACE(15)       GNB3(3)       AGTR2(2)       EDN1(2)       TNNT2(2)      NOS3(2)        ENPP1(1)      ACE2(1)
  Venous Thrombosis                                  F5(8)         F2(5)         SERPINE1(4)    MTHFR(3)      ABO(2)        F8(2)          JAK2(2)       PROCR(2)
  Cardiovascular Diseases                            APOE(7)       CETP(6)       ACE(5)         NOS3(5)       PON1(4)       APOA5(4)       APOC3(4)      SERPINE1(3)
  Myocardial Ischemia                                ACE(6)        LPL(5)        NOS3(2)        ITGB3(2)      APOB(2)       AGT(1)         AGTR1(1)      SELPLG(1)
  Arteriosclerosis                                   ACE(5)        CD14(4)       PON1(3)        FGB(3)        MTHFR(3)      NOS3(3)        APOE(3)       TLR4(2)
  Cardiomyopathies                                   TTR(5)        HFE(1)        APOA1(1)       HLADQB1(1)    SOD2(1)       CCR2(1)        SELE(1)       MMP9(1)
  Heart Failure                                      ADRA2C(5)     ADRB1(5)      ACE(3)         NOS3(3)       ADRB2(3)      AMPD1(2)       SCNN1B(1)     EDN1(1)
                                                                                                                                                         
  **DISEASE CLASS - DIGESTIVE SYS. DISEASES**                                                                                                            
  Pancreatitis                                       SPINK1(15)    CFTR(5)       PRSS1(3)       HLA-DRB1(2)   HLA-A(1)      TLR4(1)        UGT1A7(1)     KRT8(1)
  Cystic Fibrosis                                    CFTR(10)      NOS1(2)       SERPINA1(2)    SPINK1(1)     CAPN10(1)     SFTPA2(1)      GCLC(1)       FCGR2A(1)
  Celiac Disease                                     HLADQB1(6)    CTLA4(6)      HLADQA1(4)     TNF(2)        PTPN22(1)     IFNG(1)        TIPARP(1)     IL21(1)
  Crohn Disease                                      IL23R(6)      NOD2(5)       TNF(5)         ABCB1(4)      CD14(4)       IBD5(3)        DLG5(3)       MIF(3)
  Liver Cirrhosis, Alcoholic                         ALDH2(6)      ACE(1)        TNF(1)         SOD2(1)       ADH1C(1)      ADH1B(1)       DRD2(1)       CYP2E1(1)
  Colitis, Ulcerative                                ABCB1(5)      IL23R(5)      TNF(4)         CD14(4)       TLR4(3)       ICAM1(3)       IL1RN(3)      CTLA4(3)
  Gastritis, Atrophic                                MPO(3)        TLR4(1)       IL13(1)        PTPN11(1)     TNF(1)        ABO(1)         CMA1(1)       IL1B(1)
  Inflammatory Bowel Diseases                        TNF(3)        ABCB1(3)      IL23R(3)       ITPA(2)       NOD2(2)       DLG5(2)        HP(2)         PON1(1)
  Cholangitis, Sclerosing                            HLADRB1(2)    HP(2)         PTPN22(1)      MMP1(1)       HLADQA1(1)    TNF(1)         HLADQB1(1)    MMP3(1)
                                                                                                                                                         
  **DISEASE CLASS - DIS. OF ENVIRONMENTAL ORIGIN**                                                                                                       
  Alcoholism                                         DRD2(17)      OPRM1(9)      SLC6A4(8)      ALDH2(7)      MAOA(6)       GABRA2(4)      NPY(4)        ADH1B(3)
  DNA Damage                                         XRCC1(7)      TP53(3)       CYP1A1(3)      GSTM1(3)      OGG1(3)       LIG4(2)        APEX1(2)      BRCA2(2)
  Substance-Related Disorders                        SLC6A4(5)     OPRM1(5)      DRD4(4)        DRD5(2)       BDNF(2)       ADH4(2)        CNR1(2)       DRD2(2)
  Fractures, Bone                                    ESR1(4)       ESR2(2)       COL1A1(2)      CYP19A1(1)    IGF1(1)       TNFRSF11B(1)   P2RX7(1)      TGFB1(1)
  Tobacco Use Disorder                               CYP2A6(3)     SLC6A3(3)     CHRNA4(2)      TH(2)         BDNF(1)       PPP1R1B(1)     SLC18A2(1)    PTEN(1)
  Cocaine-Related Disorders                          PDYN(2)       HOMER1(1)     TTC12(1)       ANKK1(1)      DBH(1)        GSTP1(1)       OPRM1(1)      
  Heroin Dependence                                  OPRM1(2)      BDNF(1)       OPRD1(1)       SLC6A4(1)     COMT(1)       MAOA(1)                      
  Spinal Fractures                                   COL1A1(2)     CYP19A1(1)    TNFRSF11B(1)   GC(1)         PLXNA2(1)     AR(1)          NOS3(1)       
                                                                                                                                                         
  **DISEASE CLASS - IMMUNE SYSTEM**                                                                                                                      
  Autoimmune Diseases                                CTLA4(8)      HLADQB1(5)    HLADRB1(4)     HLADQA1(4)    PTPN22(2)     HLA-A(2)       CYP2D6(2)     CIITA(2)
  Hypersensitivity, Immediate                        IL4R(8)       IL13(4)       CD14(4)        IL4(2)        SERPINE1(2)   CCL5(2)        NOS2A(2)      CTLA4(2)
  Graft vs Host Disease                              IFNG(3)       TNF(2)        TLR4(1)        NOD2(1)       HLA-DPB1(1)   HLA-A(1)       IL10(1)       IL1R1(1)
  Hypersensitivity                                   IL4(3)        STAT6(3)      IL4R(2)        IFNG(1)       IFNGR1(1)     TLR2(1)        FADS1(1)      IL13(1)
  Antiphospholipid Syndrome                          F2(2)         SELPLG(1)     SERPINE1(1)    FCGR2A(1)     HLADMA(1)                                  
  Food Hypersensitivity                              IL4(1)        IL4R(1)       STAT6(1)       IL13(1)       HLADQB1(1)    CD14(1)                      
                                                                                                                                                         
  **DISEASE CLASS - MENTAL DISORDERS**                                                                                                                   
  Schizophrenia                                      DRD3(24)      HTR2A(18)     DRD2(14)       COMT(10)      HTR2C(8)      BDNF(8)        DRD4(8)       NOTCH4(8)
  Attention Deficit Disorder with Hyperactivity      DRD4(17)      SLC6A3(7)     SLC6A4(6)      ADRA2A(4)     MAOA(3)       SNAP25(3)      SLC6A2(2)     DRD5(2)
  Depressive Disorder                                SLC6A4(13)    HTR2A(4)      TPH1(3)        CYP2D6(2)     CYP2C19(2)    MAOA(2)        BDNF(2)       DRD2(2)
  Depressive Disorder, Major                         SLC6A4(13)    TPH1(5)       HTR2A(4)       TPH2(3)       BDNF(2)       DRD2(2)        GNB3(2)       DTNBP1(1)
  Bipolar Disorder                                   SLC6A4(10)    BDNF(6)       MAOA(5)        COMT(5)       XBP1(3)       GABRA5(3)      HTR2A(3)      TPH2(3)
  Anxiety Disorders                                  SLC6A4(7)     MAOA(3)       PLXNA2(1)      BDNF(1)       DBI(1)        MED12(1)       GABRB3(1)     DRD2(1)
  Mood Disorders                                     SLC6A4(5)     DRD4(4)       CLOCK(2)       MAOA(2)       BDNF(2)       ACE(1)         CRH(1)        DRD3(1)
  Psychotic Disorders                                DRD3(5)       SLC6A4(3)     DRD4(3)        HTR2A(3)      DTNBP1(2)     DISC1(2)       DRD2(2)       MAOA(1)
  Obsessive-Compulsive Disorder                      SLC6A4(4)     HTR2A(3)      COMT(3)        SLC1A1(2)     DRD4(2)       HTR1B(1)       BDNF(1)       NRCAM(1)
  Panic Disorder                                     CCK(4)        HTR1A(2)      MAOA(2)        HTR2A(2)      DBI(1)        CCKAR(1)       ADORA2A(1)    PGR(1)
  Cognition Disorders                                APOE(3)       BDNF(3)       DRD4(2)        COMT(2)       HMGCR(1)      DTNBP1(1)      SLC6A4(1)     NQO1(1)
                                                                                                                                                         
  **DISEASE CLASS - NERVOUS SYSTEM DISEASES**                                                                                                            
  Alzheimer Disease                                  APOE(70)      PSEN1(14)     A2M(10)        CYP46A1(8)    ACE(7)        BCHE(7)        IL1A(7)       BDNF(6)
  Parkinson Disease                                  PARK2(9)      LRRK2(9)      CYP2D6(7)      MAOB(7)       BDNF(5)       SNCA(5)        PON1(4)       PINK1(4)
  Multiple Sclerosis                                 HLADRB1(8)    APOE(5)       CTLA4(4)       PTPRC(4)      MBP(3)        HLA-DQB1(3)    IFNG(2)       CRYAB(2)
  Amyotrophic Lateral Sclerosis                      SOD1(6)       PON1(2)       PON2(2)        VEGFA(2)      SMN1(1)       MAPT(1)        MT-ND5(1)     PON3(1)
  Brain Ischemia                                     FGB(5)        PDE4D(3)      NOS3(3)        ACE(2)        PON1(2)       MTHFR(2)       ITGB3(2)      TLR4(1)
  Cerebrovascular Accident                           NOS3(5)       APOE(5)       FGB(5)         PON1(4)       SERPINE1(3)   ALOX5AP(3)     ACE(2)        KL(2)
  Carotid Artery Diseases                            NOS3(4)       PON1(3)       MTHFR(3)       CCL2(2)       IL6(2)        APOE(2)        CD14(2)       ACE(1)
  Dementia                                           APOE(4)       MAPT(3)       MT-ND1(1)      PRNP(1)       PSEN1(1)      TNF(1)         CDC2(1)       IGF1R(1)
                                                                                                                                                         
  **DISEASE CLASS - NUTR. AND METABOLIC DISEASES**                                                                                                       
  Diabetes Mellitus, Type 2                          ACE(25)       PPARG(18)     ADIPOQ(17)     TCF7L2(15)    CAPN10(14)    HNF4A(13)      FABP2(12)     NOS3(10)
  Obesity                                            ADRB3(17)     LEPR(12)      MC4R(11)       PPARG(11)     UCP2(11)      ADRB2(10)      UCP1(8)       ADIPOQ(8)
  Insulin Resistance                                 ADIPOQ(11)    FABP2(10)     INSR(7)        IRS1(7)       ENPP1(7)      ADRB3(6)       NOS3(6)       ACE(5)
  Diabetes Mellitus                                  PPARG(6)      ACE(3)        INS(3)         NOS3(3)       PON1(2)       UBL5(2)        IRS1(2)       TCF7L2(2)
  Hyperlipidemias                                    APOA5(5)      FABP2(4)      LPL(3)         APOE(3)       ACE(2)        APOA1(2)       PPARA(2)      PPARG(2)
  Hypertriglyceridemia                               APOC3(5)      APOA5(4)      LPL(3)         APOE(3)       ADRB2(2)      APOA4(2)       GP1BA(1)      LTA(1)
  Glucose Intolerance                                LEPR(3)       ADIPOQ(3)     IGF1(2)        KCNJ11(2)     PTPN1(2)      PPARG(2)       HNF4A(2)      NEUROG3(1)
  Hypercholesterolemia                               APOA1(3)      APOB(3)       F12(3)         ACE(2)        LDLR(2)       LPL(2)         PCSK9(2)      ABCG8(2)
  Metabolic Syndrome                                 APOC3(3)      UBL5(2)       NOS3(2)        ACE(1)        PPARD(1)      NPY5R(1)       ACE2(1)       RGS2(1)
                                                                                                                                                         
  **DISEASE CLASS - EYE DISEASES**                                                                                                                       
  Macular Degeneration                               CFH(19)       APOE(4)       PON1(2)        C2(1)         CFB(1)        ABCA1(1)       HTRA1(1)      MELAS(1)
  Diabetic Retinopathy                               VEGFA(7)      AKR1B1(4)     PON1(3)        RAGE(3)       AGER(3)       ACE(2)         ITGA2(2)      ICAM1(2)
  Glaucoma                                           CYP1B1(3)     OPTN(2)       OPA1(2)        OPTC(1)       EDNRA(1)      MYOC(1)                      
  Ocular Hypertension                                OPTN(2)       CYP1B1(1)     OLFM2(1)       OPA1(1)                                                  
  Cataract                                           GALT(1)       AIPL1(1)      IFNGR1(1)      GCNT2(1)                                                 
  Retinal Degeneration                               NDP(1)        GUCA1A(1)     AIPL1(1)       COL2A1(1)     RHO(1)        GUCA1B(1)      ABCA4(1)      
  Myopia                                             HLADPB1(1)    LUM(1)        COL2A1(1)      NYX(1)        MYOC(1)                                    

###### 

Selected Mouse Disease Related Phenotypes

  PhenoCode    PhenoType                                                                                                                                             
  ------------ ----------------------------------------------------------------------- ------------ ------------ ------------ ------------ ------------ ------------ -------------
               **DISEASE CLASS CARDIOVASCULAR**                                        **Gene 1**   **Gene 2**   **Gene 3**   **Gene 4**   **Gene 5**   **Gene 6**   **Gene 10**
                                                                                                                                                                     
  MP:0005048   thrombosis                                                              Abca5        Actc1        Adamts13     Ahr          Alox12       Anxa2        F2rl2
  MP:0005341   decreased sus. to atherosclerosis                                       APOA1        Apoe         Artles       Ath17        Ath29        Ath37        Icam1
  MP:0000231   hypertension                                                            Abcc9        Ace2         Add2         Agt          Alb1-Ren     Bpq5         Chga
  MP:0004181   abnormal carotid artery morphology                                      Aldh1a2      Chrd         Crk          Ednra        Fgf8         Foxm1        Shc1
  MP:0004111   abnormal coronary artery morph.                                         Adm          Ahr          Fgf8         Gja1         Hspg2        Itga4        Vegfa
  MP:0005338   atherosclerotic lesions                                                 Aorls1       Aorls2       Apoe         Ath29        Ath6         Ath8         Fabp4-Aebp1
  MP:0000343   altered resp. to myocardial infarction                                  Agtr2        Aifm1        Ak1          Bnip3        CMV-Abcc9    Ccr1         Ckm-Prkaa2
  MP:0006058   decreased cerebral infarction size                                      ACTB-Ngb     EGFP         Adora2a      Cx3cl1       F11          F12          Plat
  MP:0003037   increased infarction size                                               Aifm1        Fgf2         Hmox1        Kit          Mapk1        Myh6-tTA     Thbd
  MP:0004875   Inc. mean arterial blood pressure                                       Ddah1        Edn1         Ednrb        Kcnn3        Ptger1       Tagln-tTA    
  MP:0005339   Inc. susceptibility to atherosclerosis                                  Apoa1        Apoe         Artles       Ascla1       Ascla2       Ascla3       Ath18
                                                                                                                                                                     
               **DISEASE CLASS - DIGESTIVE SYSTEM DISEASES**                           **Gene 1**   **Gene 2**   **Gene 3**   **Gene 4**   **Gene 5**   **Gene 6**   **Gene 10**
                                                                                                                                                                     
  MP:0003119   abnormal digestive system dev.                                          Cdkn1c       Cyp26a1      Foxp4        Mapk7        Mcm4         Nckap1       Tbx6
  MP:0000462   abnormal digestive system morph.                                        Apc          Bmp5         Cdcs1        Cdkn1c       Cftr         Ctnnbip1     Gast
  MP:0001663   abnormal digestive system phys.                                         Apoe         Cd44         Cftr         Clec7a       Col2a1       Fut2         Gpx1
  MP:0000474   abnormal foregut morphology                                             Apc          Foxa2        Gata4        Gdf1         Hgs          Ldb1         Otx2
  MP:0000488   abnormal intestinal epithelium morph                                    Atr          B4galt1      B9d2         Bdkrb2       Cbfa2t2      Col1a1       Elf3
  MP:0003449   abnormal intestinal goblet cells                                        Areg         Cbfa2t2      Cftr         Clca3        Ctnnb1       E2f4         Il13
  MP:0006001   abnormal intestinal transit time                                        Drd2         Gfra2        Gucy1b3      Hmox2        Mrvi1        Smtn         
  MP:0000470   abnormal stomach morphology                                             Ahr          Aire         Barx1        Celsr3       Cfc1         Col1a1       Gdf11
                                                                                                                                                                     
               **DISEASE CLASS - DIS. OF ENVIRONMENTAL ORIGIN**                        **Gene 1**   **Gene 2**   **Gene 3**   **Gene 4**   **Gene 5**   **Gene 6**   **Gene 10**
                                                                                                                                                                     
  MP:0001425   abnormal alcohol consumption                                            Aaq1         Alcp1        Alcp19       Alcp2        Ap7q         Ap8q         Ppp1r1b
  MP:0005443   abnormal ethanol metabolism                                             Adh1         Adh7         Afteq1       Afteq2       Alcw3        Htas2        
  MP:0002552   abnormal response to addictive sub.                                     Adora2a      Adra1d       Alcw1        Alcw2        Alcw3        Alcw4        Chrna4
  MP:0001987   alcohol preference                                                      Alcp1        Alcp25       Alcp3        Alcp4        Alprf        Ap1q         Ap5q
  MP:0001988   cocaine preference                                                      Grm2         Homer1       Homer2       Per2         Slc6a3       Slc6a4       
  MP:0003546   decreased alcohol consumption                                           Camk2a       Gnas         Gria3        Prkce        tmgc55                    
  MP:0004048   resistance to addictive substance                                       Adora2a      Adra1b       Apba1        Aqp4         Btbd14b      Chrna4       Slc6a3
                                                                                                                                                                     
               **DISEASE CLASS - IMMUNE SYSTEM DISEASES**                              **Gene 1**   **Gene 2**   **Gene 3**   **Gene 4**   **Gene 5**   **Gene 6**   **Gene 10**
                                                                                                                                                                     
  MP:0001844   autoimmune response                                                     Tcra         Tcrb         ACTB         Aire         Cd1d1        Fas          Ikzf3
  MP:0005016   decreased lymphocyte cell number                                        Atm          Bcl2         Bcl6b        Birc2        C3ar1        Ccr9         Ctsd
  MP:0008088   abnormal T-helper 1 cell diff.                                          Cbfb         Ifngr2       Il2          Il4          Irf4         Mapk8        Sit1
  MP:0002499   chronic inflammation                                                    Ccr7         Gstz1        Hmox1        Il10         Il1rn        Jak3         Plcg2
  MP:0004804   dec. sus. to autoimmune diabetes                                        HLA-DQA1     HLA-DQB1     Art2a        B2m          Cd4          Cd4DsRed     Cdk4
  MP:0002411   decreased sus. to bacterial infection                                   Anth         Anth2        B2m          C4b          Casp1        Cd97         Dcn
  MP:0005597   dec. sus. to type I hypers-reaction                                     Alox5        Alox5ap      Cysltr1      Cysltr2      Fcer1a       Fcer1g       Orai1
  MP:0003725   increased autoantibody level                                            Tcra         Tcrb         Acla1        Acla2        Aire         Cd276        Cia38
  MP:0005014   increased B cell number                                                 BCL2         Bak1         Bax          Bcl11b       Bcl2l11      Bst1         Cdkn2c
  MP:0005013   increased lymphocyte cell number                                        Axl          B4galt1      Bak1         Casp8        Cd19         Ewsr1        Galnt1
  MP:0004803   Inc. sus. to autoimmune diabetes                                        Ins1-Cat     Tyr          B2m          Cd274        Cd28         Cd38         Cdk2
  MP:0005350   Inc. sus. to autoimmune disorder                                        Tcra         Tcrb         Ads1         Ads2         Ads3         Ads4         Bak1
  MP:0002412   increased sus. to bacterial infection                                   Adamts13     Adcyap1r1    Adh5         Atf2         Bbaa21       Bcl10        C3
                                                                                                                                                                     
               **DISEASE CLASS - MENTAL DISORDERS DISEASE CLASS - MENTAL DISORDERS**   **Gene 1**   **Gene 2**   **Gene 3**   **Gene 4**   **Gene 5**   **Gene 6**   
                                                                                                                                                                     
  MP:0001412   excessive scratching                                                    Atp2b4       Bdnf         Ctsl         EIF1AX       Lck-Il31ra   Mapt         **Gene 10**
  MP:0001362   abnormal anxiety-related response                                       App          Araf         Axtofd1      Axtofd3      Axtofd4      Axtofd5      
  MP:0001458   abnormal object recognition memory                                      Gabbr1       Gal          Grin1        Prnp         Prnp-App     Psen1        Crhr1
  MP:0001360   abnormal social investigation                                           Avpr1a       Avpr1b       Cadps2       En2          Gnao1        Grin1        
  MP:0002557   abnormal social/conspecific int.                                        Ar           Cadps2       Disc1        En2          Grin1        Grin3b       Maoa
  MP:0002065   abnormal fear/anxiety-related beh.                                      APPV717I     App          Atp1a2       Crebbp       Egr1         Gnai1        Oxt
  MP:0001364   decreased anxiety-related response                                      APP          Adcy8        Adcyap1      Adcyap1r1    Avpr1a       B3galt2      Nos3
  MP:0002573   behavioral despair                                                      Adra2c       B3gnt2       Cacna1c      Crhr2        Desp1        Desp2        Camk2a
  MP:0001462   abn. avoidance learning behavior                                        Aal          Aap          Dcx          Idua         Ntrk2                     Nr3c1
                                                                                                                                                                     
               **DISEASE CLASS - NUTR. AND METABOLIC DISEASES**                        **Gene 1**   **Gene 2**   **Gene 3**   **Gene 4**   **Gene 5**   **Gene 6**   
                                                                                                                                                                     
  MP:0005560   decreased circulating glucose level                                     Ins1-Cat     Tyr          Acadm        Adipoq       Apcs-Lep     Apoe         **Gene 10**
  MP:0004185   abnormal adipocyte glucose uptake                                       Akt2         Bglap1       Cebpa        Pik3r1       Prkci        Ptprv        Cd36
  MP:0000188   abnormal circulating glucose level                                      Adipor1      Cidea        Ciita        Ckm          Crh          Dbm3         
  MP:0001560   abnormal circulating insulin level                                      Cacna1c      Cebpa        Foxa1        Gal          Gck          IGFBP2       Irs2
  MP:0003383   abnormal gluconeogenesis                                                Adipoq       Adipor1      Cebpa        Cebpb        Lpin1        Mc2r         Mgat4a
  MP:0005291   abnormal glucose tolerance                                              Adipoq       Fstl3        Irs4         Lep          Pcsk1        Pnpla2       Smarcb1
  MP:0003564   abnormal insulin secretion                                              Eif2ak3      Gast         Gck          Gjd2         Ins2         Lep          
  MP:0002727   decreased circulating insulin level                                     Adcyap1r1    Adipor2      Ahsg         Akt2         Apcs-Lep     Apoa2        
  MP:0002711   decreased glucagon secretion                                            Cacna1e      Dbh          Kcnj11       Nkx2-2       Pcsk2                     Bglap1
  MP:0003059   decreased insulin secretion                                             Abcc8        Anxa7        Bglap1       Cacna1e      Cartpt       Chrm3        
  MP:0001548   hyperlipidemia                                                          APOC1        Acox1        Apc          Apoe         Cdkn1b       Cpt1c        Eif2s1
  MP:0005293   impaired glucose tolerance                                              APPswe       PSEN1dE9     Abcc8        Acadvl       Adcyap1r1    Adipoq       Lepr
  MP:0005292   improved glucose tolerance                                              Adipor2      Ahsg         Bcat2        Cbl          Crebbp       Cxcl14       Akt2
  MP:0004892   increased adiponectin level                                             Actb         Adipor2      Cideb        Crebbp       Pde3b        Pten         Gcgr
  MP:0002575   Inc. circulating ketone body level                                      Acacb        Adcyap1      Gck          AZIP         Ins2         Ins2-Nos2    Scd1
  MP:0003645   Inc. pancreatic beta cell number                                        ACTB         Akt2         Arx          Hnf4a        Cdkn1b       Foxo1        Ins2-rtTA
  MP:0001759   increased urine glucose level                                           Aqp1         Aqp7         Cdk4         Cdk4         Cryaa-TAg    Dnajc3a      Ins1
  MP:0005331   insulin resistance                                                      APOB         Adipoq       Adipor1      Clcn5        Adra1b       Akt2         Bglap1
                                                                                                                                                                     
               **DISEASE CLASS - EYE DISEASES**                                        **Gene 1**   **Gene 2**   **Gene 3**   **Gene 4**   **Gene 5**   **Gene 6**   **Gene 10**
                                                                                                                                                                     
  MP:0001299   abnormal eye distance/position                                          Dst          Edg2         Hectd1       Hesx1        Itgb1        Nrtn         
  MP:0000776   abnormal inferior colliculus                                            Atg5         En1          Ext1         Fgf17        Fgf8         Fgfr1        
  MP:0003236   abnormal lens capsule morphology                                        Abi2         Cdkn2a       Cryaa        Cryga        Hsf1         Hsf4         Otx2
  MP:0002864   abnormal ocular fundus morphology                                       Crb1         Gpr143       Mitf         Pitx3        Rd9          Rp1h         
  MP:0002638   abnormal pupillary reflex                                               Cat4         Cnga3        Cry1         Eccp         Foxe3        Iac          tmgc25
  MP:0002699   abnormal vitreous body                                                  Aldh1a1      Aldh1a3      Bmp4         Cdkn2a       Fzd4         Gas1         
  MP:0001314   corneal opacity                                                         Alm          Apo          Areg         Bmp4         Cat4         Col4a1       Lim2
  MP:0001851   eye inflammation                                                        Adam17       Atf2         Eda          Fign         ITGA2        ITGA5        Dsc1
  MP:0005542   corneal vascularization                                                 Dstn         Eda          Fign         Flt1         Foxe3        Ifnar1       Plg
  MP:0003011   delayed dark adaptation                                                 Rbp1         Rdh11        Rdh12        Rdh5         Rdh8         Rlbp1        Pgf
  MP:0005172   reduced eye pigmentation                                                Ap3b1        Ap3d1        Hps5         Hps6         Mitf         Nf1          Sema4a

### Human

Table [4](#T4){ref-type="table"} shows examples of selected genes in each row that have been positively associated with specific disease phenotype keywords. Each human gene symbol is followed by a specific MeSH disease term and the number of times that gene has been positively associated with the term, in declining order. A major feature of Table [4](#T4){ref-type="table"} is that individual genes have been positively associated with sometimes overlapping disease phenotypes over a broad range from more frequently to less frequently. Table [4](#T4){ref-type="table"} is a small representative subset, truncated in the number of genes (rows) and the number of MeSH terms (columns). The complete list of 1,584 human genes with additional information can be found in Table S1a \[[@B20]\]. An interactive version of the same list can be found in Table S1b\[[@B21]\].

Quite often the resulting list of phenotypes associated with a specific gene may include the major disease phenotype followed by specific sub-phenotypes of the disease that contribute distinct aspects to the overall clinical disease phenotype. For example, IL13 has been associated with asthma at least 11 times as well as to the asthma sub-phenotype immediate hypersensitivity 4 times. Similarly, the gene CFH has been associated with macular degeneration at least 19 times, as well as to the endo-phenotype of macular degeneration, choroidal neovascularization 3 times. Although replication in genetic association studies has been widely debated\[[@B22]\], consistent replication by independent groups, although sometimes with both modest risk and significance values\[[@B23]\], suggests a fundamental measure of scientific validity. This is true for both candidate gene as well as GWAS studies.

In other cases, individual genes have been associated with independent but related disorders that may share fundamental biological pathways in disease etiology, such as HLA-DQB1, CTLA4, and PTPN22 as in the case of autoimmune disorders. This gene overlap emphasizes the fundamental, often step-wise biochemical role each gene plays in shared disease etiology \[[@B24]-[@B27]\]. That is, HLA-DQB1 in antigen presentation, CTLA4 in regulation of the expansion of T cell subsets, and PTPN22 in T cell receptor signaling, all contributing to immunological aberrations and progression to clinical disease, as in rheumatoid arthritis, systemic lupus erythematosus, and type 1 diabetes. In other cases, the same gene has been associated with quite different clinical phenotypes, suggesting sharing of complex biological mechanisms at a more underlying level. For example, the gene CFTR, widely recognized as the cause of cystic fibrosis, has been consistently associated with pancreatitis, may be implicated in chronic rhinitis \[[@B28]\], and may play a protective role in gastrointestinal disorders \[[@B29]\].

### Mouse

Tables [5](#T5){ref-type="table"} and S2 are the mouse equivalents of the human GENE-to-Disease/Phenotype lists (tables [4](#T4){ref-type="table"} and S1 for human). These were developed from the mouse phenotype table of genes with mouse phenotype ontological codes <ftp://ftp.informatics.jax.org/pub/reports/index.html#pheno>, downloaded on 4-4-08. To build tables [5](#T5){ref-type="table"} and S2, the matching phenotypic terms were exchanged for each Mammalian Phenotype code (MP:\#). This resulted in the mouse GENE-to-Disease/Phenotype tables (tables [5](#T5){ref-type="table"} and S2) similar in structure to human GENE-to-Disease/Phenotype tables (tables [4](#T4){ref-type="table"} and S1). Unlike the human tables, the mouse GENE-to-Disease/Phenotype tables come from individual mouse experimental knockout or other genetic studies. They are not based on population based epidemiological studies. They also do not have the quantitative aspect of the human tables with publication frequency counts tagged to each record. In addition, although they include a wide variety of physiological, neurological, and behavioral phenotypes, they do emphasize developmental studies and observational morphological phenotypes common in mouse knockout studies. Table [5](#T5){ref-type="table"} is a small representative subset, truncated in the number of genes (rows) and the number of Phenotype terms (columns). The complete list of 5011 mouse genes with annotated phenotypes and additional information can be found in Table S2a\[[@B30]\]. An interactive version of the same list can be found in Table S2b\[[@B31]\].

### Direct comparison of human and mouse genes disease/phenotypes

We can now compare these tables directly, thereby allowing gene-by-gene comparison of human disease phenotypes and mouse genetic phenotypes. Tables [6](#T6){ref-type="table"} and S3 are comparisons of the genes that overlap between the human and mouse gene lists (Table S1 and Table S2) showing mouse gene symbols and their human orthologs. Table [6](#T6){ref-type="table"} is a small subset of selected gene-phenotype cross species comparisons. Even though in some cases the human studies have not been replicated, there is often a striking concordance between human disease phenotypes and mouse genetically determined phenotypes. For example, the human gene inhibin alpha (INHA) has been associated with premature ovarian failure\[[@B32]\], and shows mouse phenotypes of abnormal ovarian follicle morphology, female infertility, and ovarian hemorrhage\[[@B33]\], among other phenotypes relevant to human disease. Similarly, in humans the engrailed homeobox 2 gene (EN2) has been associated with autistic disorder\[[@B34]\] while the comparison to mouse En2 has genetic mutations involved in abnormal social integration, spatial learning, and social/consecutive interaction, among others\[[@B35]\]. Importantly, the few mouse studies highlighted above, and many found in the main table S3, were published *after*the corresponding human genetic population based epidemiological studies. Given concerns of false positives and publication bias in human genetic association studies, direct comparisons to related mouse phenotypes may provide supporting evidence that a given gene may be relevant to a specific human disease phenotype. Table S3\[[@B36]\] is a full listing of the 1104 shared genes between the human disease and mouse phenotype summaries.

Summaries of phenotypes and genes in human and mouse
----------------------------------------------------

The second type of main summary tables are DISEASE/PHENOTYPE-to-Gene lists. Disease/Phenotype gene summaries are essentially transposed versions of the GENE-to-Disease/Phenotype summaries (Tables S1 & S2) that allow different types of comparisons. These are non-redundant lists of phenotype keywords, MeSH disease terms in the case of human and Mammalian Phenotype Terms (MP) in the case of mouse, followed by the genes associated or annotated to those disease phenotype keywords.

### Human

Table [7](#T7){ref-type="table"} shows examples of selected human disease phenotypes in each row positively associated with specific human genes for 8 major MeSH disease classes including cardiovascular, digestive system diseases, diseases of environmental origin, immune system diseases, mental disorders, nervous system diseases, nutritional and metabolic diseases, and eye diseases. Each Mesh phenotype term is followed by the number of times that a specific disease term has been positively associated with a particular gene in each row, in decreasing order. Table [7](#T7){ref-type="table"} is a small representative set, truncated in the number of disease phenotypes (rows) and the number of genes (columns). The complete list of 1,318 MeSH disease phenotype terms with additional information can be found in Table S4a\[[@B37]\]. An interactive version of the complete list can be found in Table S4b\[[@B38]\].

### Mouse

Tables [8](#T8){ref-type="table"} and S5 constitute the mouse DISEASE/PHENOTYPE-to-Gene summaries. Table [8](#T8){ref-type="table"} consists of selected mouse phenotypes which fall into similar general classes of the human table [7](#T7){ref-type="table"} followed by 6 representative genes that have been assigned to the appropriate phenotypic term due to a specific mouse genetic model. Unlike the human Disease/Phenotype-to-gene tables [7](#T7){ref-type="table"} and S4, the mouse tables [8](#T8){ref-type="table"} and S5 do not have quantitative information. Table [8](#T8){ref-type="table"} is also a small representative set, truncated in the number of disease phenotypes (rows) and the number of genes (columns). The complete list of 5,142 mouse phenotype terms with their corresponding Mammalian PhenoCode designations can be found in Table S5a\[[@B39]\]. An interactive version of the complete list can be found in Table S5b\[[@B40]\].

Using disease and gene lists
----------------------------

The purpose of this project is not simply to generate lists and information. It is to provide a distillation of disease and phenotype information that can be used in dissecting the complexities of human disease and mouse biology. Now that we have generated GENE-to-disease/phenotype summaries and DISEASE/PHENOTYPE-to-gene summaries for both mouse and human, they can be used for systematic analysis, comparison, and integrating of orthologous data with the goal of providing higher order interpretations of human disease and mouse genetically determined phenotypes.

### Human disease and mouse phenotype based gene sets

Gene sets have been defined simply as groups of genes that share common biological function, chromosomal location, or regulation\[[@B41]\]. Gene sets are used in high-throughput systematic analysis of microarray data using a priori knowledge. Unlike previously defined gene sets based on biological pathways or differentially expressed genes\[[@B41]\], GAD disease gene sets are unique in that they are composed of genes that have been previously shown to be both polymorphic and have been determined to be genetically positively associated with a specific disease phenotype in a human population based genetic association study. Similarly, Table S5a\[[@B39]\] the mouse DISEASE/PHENOTYPE-to-Gene list is used as a source for gene sets for mouse phenotypes (MP gene sets) comprised of unique gene based mouse genetic models. These gene set files are currently the largest set of gene set files publicly available and the only gene sets files where each gene is based on direct human or mouse genetic studies.

### Comparison of individual GAD disease gene sets

One aspect of common complex disease is that the development of disease and disease phenotypes quite often present along a broad spectrum of symptoms and share clinical characteristics, endo-phenotypes, or quantitative traits with closely related disorders \[[@B25]\]. This is evident in gene sharing, as mentioned above, and equally in the overlap of biological pathways between related disorders. Using GAD disease gene sets, Venn diagram comparisons among related disorders shows modest gene sharing. However, when gene sets are then placed into biological pathways and compared by Venn analysis, there is a marked increase in the overlap in pathways between related disorders. This was not found in gene sets from unrelated disorders. For example, major autoimmune disorders quite often share endophenotypes of lymphoproliferation, autoantibody production, and alterations in apoptosis, as well as other immune cellular and biochemical aberrations. As shown in Figure [1a](#F1){ref-type="fig"}, genes that have been positively associated with type 1 diabetes, rheumatoid arthritis, and Crohn\'s disease show a modest overlap. However, when individual gene sets are fitted into biological pathways, then compared for overlap of pathway membership, there is a striking increase in the overlap at the pathway level. This is true in a comparison of gene and pathways for type 2 diabetes, insulin resistance, and obesity as well (Figure [1b](#F1){ref-type="fig"}). This pattern of major pathway overlap does not seem to occur between unrelated disorders, such as insulin resistance, rheumatoid arthritis and bipolar disorder (Figure [1c](#F1){ref-type="fig"}). This disease related sharing at the pathway level suggests common regulatory mechanisms between these disorders and that the original positive associations are not necessarily due to random chance alone.

![**Venn Diagram analysis of individual GAD disease gene sets (circles) versus pathways (rectangles) produced from the corresponding gene set**. All Venn Diagrams were produced with Venny <http://bioinfogp.cnb.csic.es/tools/venny/index.html>.](1755-8794-3-1-1){#F1}

### Group analysis of GAD disease gene sets between major classes of disease/phenotypes

#### Dendrogram analysis of human disease gene sets

As archival information grows, analysis of complex molecular and genetic datasets using clustering or network approaches has become increasingly more useful \[[@B13],[@B42]-[@B45]\]. Therefore, in addition to comparisons between individual diseases using human and mouse gene sets, we analyzed large gene groups using dendrogram and clustering approaches based on gene sharing between gene sets. Figure [2](#F2){ref-type="fig"} shows a broad based dendrogram comparison based on gene sharing between 480 GAD disease gene sets, using gene sets each containing at least 3 genes. A striking feature of this analysis is that at a coarse level, major disease groups cluster together in space demonstrating shared genes between major clinically important disease groups. Disease domains are represented by groups such as cardiovascular disorders, metabolic disorders, cancer, immune and inflammatory disorders, vision, and chemical dependency. At finer detail within a specific broader group, it becomes clear that individual diseases with overlapping phenotypes are found close in space, such as asthma, allergic rhinitis, and atopic dermatitis. This overlap due to gene sharing recapitulates an overlap in clinical characteristics between these related disorders. Similarly, phenotypes within the metabolic group related to diabetes are closely aligned in space including; insulin resistance, hyperglycemia, hyperinsulinemia, and hyperlipidemia. This close apposition of related disease phenotypes and sub-phenotypes at both a coarse and fine level is a consistent feature of the overall display. The human gene sets used in creating this tree diagram can be found in Table S6\[[@B46]\]. It is important to emphasize that this display and the distance relationships between diseases are calculated through an unbiased gene-sharing algorithm independent of disease phenotype labels and not as a result of an imposed logical hierarchy or an ontological annotation system. This grouping of major disease phenotypes based solely on gene sharing provides supporting evidence that the underlying disease based gene sets may have a fundamental relevance to disease and may not be reported in the literature by chance alone.

![**Human dendrogram comparison of 480 GAD disease gene sets based on gene sharing**. The input GAD gene set file for this figure can be found in Table S6\[[@B46]\].](1755-8794-3-1-2){#F2}

#### Dendrogram analysis of mouse phenotypic gene sets

Figure [3](#F3){ref-type="fig"} is a similar dendrogram to the human tree using 1056 mouse phenotypic gene sets, using gene sets each containing at least 10 genes. This was produced using the same gene sharing algorithm as for the human gene sets in Figure [2](#F2){ref-type="fig"}. As with the human dendrogram, the mouse tree displays informative groupings at both a coarse and fine level. This tree groups into major groupings nominally assigned as brain development and brain function, embryonic development, cardiovascular, reproduction, inflammation, renal function, bone development, metabolism, and skin/hair development. The identification of major groupings emphasizing developmental processes reflects the emphasis of gene knockouts and developmental models resulting in observable morphological traits and less so with regard to end stage clinical diseases as in the human dendrogram. Like the human dendrogram (Figure [2](#F2){ref-type="fig"}) discrete major functional groupings in the mouse dendrogram suggests that individual experimental observations are not random. Fundamental complex processes such as metabolism, cardiovascular phenomena, and developmental processes are integrated by extensive sharing of related pliotropic genes. Moreover, like the human tree, fine structure in the mouse tree shows related mouse phenotypes are closely positioned in space. For example, in the metabolism major grouping, the individual phenotypes of body mass, adipose phenotypes, and weight gain are closely positioned. Similarly, in the brain function group, the behavioral phenotypes of anxiety, exploration, and responses to novel objects are found next to one another. This pattern is a fundamental feature of this tree. Like the human tree, the mouse dendrogram shown here is based solely on a gene sharing algorithm using genes assigned to individual phenotypes. It is not based on an imposed predetermined hierarchy or ontology. Importantly, unlike the human tree, the information contained in the mouse tree is derived from individual independent mouse genetic studies and phenotypic observations and not from large case controlled population based epidemiological studies. Controversial issues such as publication bias or study size which confound human genetic association studies are not as relevant here in the context of studies of experimentally determined individual mouse gene knockouts and related studies. The mouse gene sets used in creating this tree diagram can be found in Table S7\[[@B47]\].

![**Mouse dendrogram comparison of 1056 mouse phenotype (MP) gene sets based on gene sharing**. The input MP gene set file for this figure can be found in Table S7\[[@B47]\].](1755-8794-3-1-3){#F3}

#### Hierarchical clustering of human and mouse gene sets

Hierarchical clustering has become a common tool in the analysis of large molecular data sets\[[@B48]\] allowing identification of similar patterns in a scalable fashion from the whole experiment down to a level of fine structure. To provide further evidence of disease relevance and biological content contained in both the human and mouse gene sets hierarchical clustering was performed on both human and mouse. Four hundred and eighty human gene sets were clustered producing 46 major disease clusters. In the mouse, clustering was performed on 2067 mouse phenotype gene sets, using gene sets containing at least 3 genes. This resulted in 165 major subgroups of functional phenotypic specificity. Hierarchical clustering is shown for human \[Additional file [1](#S1){ref-type="supplementary-material"} and Additional file [2](#S2){ref-type="supplementary-material"}\] and for mouse \[Additional file [3](#S3){ref-type="supplementary-material"} and Additional file [4](#S4){ref-type="supplementary-material"}\]. Like the human and mouse dendograms, this hierarchical clustering showed functional disease grouping at both a coarse group level and at a fine level within major phenotypic groupings. These clusters in both human and mouse falling into closely defined broad functional groups as well as closely related clinical, physiological, and developmental phenotypes demonstrates a general pattern of relevance to disease in their original underlying genetic associations. As in the dendrogram displays, this suggests that the genes nominally positively associated to these disorders, drawn from the medical literature, are not pervasively randomly assigned or due to a widespread pattern of random false positives associations.

Discussion and Conclusion
=========================

This report describes a summary of the positive genetic associations to disease phenotypes found in the Genetic Association Database as well as a summary of mouse genetically determined phenotypes from the MGI phenotypes database. The genes and disease lists described here were derived from a broad literature mining approach. We have shown disease relevance in three distinct ways; a) in comparing individual gene lists and pathways, b) comparing between species and, c) in broad based comparative analysis utilizing complex systems approaches. Moreover, we identify disease based genes sets for 1,317 human disease phenotypes as well as 5,142 mouse experimentally determined phenotypes. These resources are the largest gene set files currently publicly available and the only gene set files derived from population based human epidemiological genetic studies and mouse genetic models of disease.

Each individual GAD disease gene set (i.e. a single disease term followed by a string of genes) or mouse phenotype gene set becomes a candidate for a number of uses and applications including:

a\) contributing to complex (additive, multiplicative, gene-environment) statistical models for any given disease phenotype \[[@B49]-[@B53]\]; b) use in comparative analysis of disease between disease phenotypes; c) use in interrogating other related data types, such as microarray (see below), proteomic, or SNP data \[[@B54]-[@B56]\]; and d) integration into annotation engines\[[@B57]\] or genome browsers\[[@B58]\] or other analytical software to add disease information in comparative genomic analysis. In a sense, each individual human or mouse disease/phenotype gene set becomes a unique hypothesis, testable in a variety of ways. Increasingly, combinations of genes may have important predictive value as combinatorial biomarkers in predicting disease risk as opposed to single candidate genes \[[@B59],[@B60]\].

In addition, in an ongoing parallel set of experiments, using a Gene Set Analysis (GSA) approach using the web tool Disease/Phenotype web-PAGE, in the analysis of orthologous microarray data (De S, Zhang Y, Garner JR, Wang SA, Becker KG: Disease and phenotype gene set analysis of disease based gene expression, unpublished), both the human and mouse disease/phenotype gene sets defined above demonstrate striking disease specificity in PAGE\[[@B61]\] gene set analysis of previously published microarray based gene expression studies from numerous independent laboratories in both a species specific and cross species manner. This was true when studying gene expression studies of type 2 diabetes, obesity, myocardial infarction and sepsis, among others, providing further evidence of the disease and clinical relevance of both the human and mouse gene sets.

This approach is limited in a number of ways. In particular, the GAD database compares the results of human population based epidemiological studies performed using different sample sizes, populations, statistical models, and at different times over approximately the last 16 years. In addition, the GAD database draws on association studies of broad quality with different degrees of detail provided. Although all human genetic association studies discussed here have been individually determined to be positively associated with a disease or phenotype in a peer reviewed journal, we make no assertion that any individual study is correct and we recognize the controversy in the genetics community regarding statistical and biological significance of genetic association studies. Moreover, although the GAD database contains information on polymorphism and variation, and each GAD record is fundamentally based on polymorphism, this report does not consider variation or polymorphism in the summaries shown. Likewise, mouse genetic models in many cases are weighted to gene knockouts which may not be necessarily be directly representative of multifactorial human common complex disease.

However, even with these limitations, we believe valuable insights can be gained from broad based literature assessments of the genetic contribution in human common complex disease and in mouse phenotypic biology. More importantly, this suggests greater opportunities for systematic mining and analysis of published data and in cross comparison of archival molecular databases in both human and animal models of disease with regard to genetic variation, population comparisons, and integration with many different types of orthologous information.
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